Antibody targeting of activated dendritic cells prevents AGVHD and preserves T cell immunity.

被引：0
|
作者：
Cullup, Hannah
Wilson, John
Rice, Alison M.
Dickinson, Anne M.
Munster, David J.
Hart, Derek N. J.
机构：
[1] Mater Med Res Inst, DC Program, Brisbane, Qld, Australia
[2] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.3240.3240
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3240
引用
收藏
页码：925A / 925A
页数：1
相关论文
共 50 条
  • [21] Antigen targeting to endosomal pathway in dendritic cell vaccination activates regulatory T cells and attenuates tumor immunity
    Maksimow, Mikael
    Miiluniemi, Mari
    Marttila-Ichihara, Fumiko
    Jalkanen, Sirpa
    Hanninen, Arno
    BLOOD, 2006, 108 (04) : 1298 - 1305
  • [22] TARGETING NOVEL PATHWAYS IN CHRONICALLY ACTIVATED T CELLS PREVENTS FUNCTIONAL EXHAUSTION
    Rzepecka, Justyna
    Hall, Andrew
    Barbour, Mark
    Mallon, Emma
    Bedaj, Marija
    Janicova, Lucia
    Cortes-Lavaud, Xabier
    Acklam, Frances
    Hay, Joanne
    Gooding, Hayley
    Turner, Darryl
    Singh, Preeti
    Crawford, Aaron
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1088 - A1088
  • [23] Dendritic cells in models of tumor immunity. Role of Flt3 ligand
    Maliszewski, C
    PATHOLOGIE BIOLOGIE, 2001, 49 (06): : 481 - 483
  • [24] FLIP in Dendritic Cells May Regulate Hematopoietic Homeostasis and Modulating Inflammation and Immunity.
    Huang, Qi Quan
    Birkett, Robert
    Perlman, Harris R.
    Pope, Richard M.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S463 - S464
  • [25] Differential effects of myeloid dendritic cells genetically engineered to express viral or mammalian IL-10 on T cell-mediated immunity.
    Takayama, T
    Tahara, H
    Thompson, AW
    TRANSPLANTATION, 2000, 69 (08) : S355 - S355
  • [26] Tolerance of activated pathogenic CD4+ T cells by transcriptional targeting of dendritic cells
    B de Andrade Pereira
    M Ackermann
    S Chaudhary
    R Vogel
    B Vogt
    C Dresch
    C Fraefel
    Gene Therapy, 2015, 22 : 382 - 390
  • [27] Tolerance of activated pathogenic CD4+T cells by transcriptional targeting of dendritic cells
    Pereira, B. de Andrade
    Ackermann, M.
    Chaudhary, S.
    Vogel, R.
    Vogt, B.
    Dresch, C.
    Fraefel, C.
    GENE THERAPY, 2015, 22 (05) : 382 - 390
  • [28] Selective elimination of alloreactive donor T cells attenuates graft versus host disease and enhances T cell immunity.
    Drobyski, W
    Gendelman, M
    Yassai, M
    Tivol, E
    Krueger, A
    Gorski, J
    BLOOD, 2003, 102 (11) : 698A - 698A
  • [29] Helper T cells, dendritic cells and CTL immunity
    Behrens, G
    Li, M
    Smith, CM
    Belz, GT
    Mintern, J
    Carbone, FR
    Heath, WR
    IMMUNOLOGY AND CELL BIOLOGY, 2004, 82 (01): : 84 - 90
  • [30] Targeting CD5 and Fas receptor on CD8+immune T cells to improve antitumor immunity.
    Koropatnick, James
    Alotaibi, Faizah
    Rytelewski, Matt
    Min, Wei-ping
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 62 - 62
12345